ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

Sandra Swain Elected ASCO President for 2012

December 10, 2010

Neoadjuvant Surgery Makes Radiation Unnecessary In Some Early Breast Cancer

September 26, 2008

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 12, 1990

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

HHS Carcinogen Guidelines Draft

June 13, 1980